Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management of hypercortisolism among people with type 2 diabetes. Episode Highlights00:39 DeFronzo Introduction01:54 Presentation of Hypercortisolism05:50 Ominous Octet and Hypercortisolism09:47 Prevalence of Hypercortisolism in T2D13:57 Impact of Untreated Hypercortisolism17:05 Screening for Hypercortisolism21:25 CATALYST Trial 31:30 Outro

Episode metadata supplied by the publisher feed · Published Jan 9, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

0:00 31:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives?

This episode is 31 minutes long.

When was this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode published?

This episode was published on January 9, 2024.

Can I download this Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!